Navigation Links
Microlife's Home Blood Pressure Monitors Proven Accurate Even for Critical Patients
Date:10/2/2007

As Widespread Use of Home Blood Pressure Monitoring Becomes Recommended and

the Need for Accurate Devices Expands to Include Critical Patients, Microlife Manufactures the Only Home Blood Pressure Monitor with Proven

Accuracy (Severe arterial-sclerosis in End Stage Renal Disease)

DUNEDIN, Fla., Oct. 2 /PRNewswire/ -- Since the release of the American Heart Association's Recommendations for Blood Pressure Measurement in 2005, more and more physicians and patients are recognizing the need to accurately monitor blood pressure at home. A "true pressure" is defined as the average level over a prolonged duration, thus measurements only taken during office visits are not a reliable indicator of one's "true" blood pressure. According to the American Heart Association patients should only measure at home with a monitor that can prove accuracy through independently validated clinical studies, take 2 or more readings and average the results, record the readings over time and be able to share these measurements with a physician. Microlife upper arm digital blood pressure monitors meet all of the recommendations set forth by the AHA. Additionally, in critical patients such as those suffering from end-stage renal disease, who often have diabetes, the need for accurate devices for home blood pressure monitoring has, until now, been seemingly unmet. According to a study published in "Blood Pressure Monitoring" (2007, 12:227-232), Microlife's upper arm monitors are shown to accurately measure pressure, even in patients with severe arterial-sclerosis in End Stage Renal Disease (ESRD).

The study, led by Professor Thomas G Pickering, M.D., shows that Microlife's upper arm monitors are the first oscillometric devices to measure blood pressure accurately against a mercury sphygmomanometer, the gold standard, in this highly critical patient group. According to Professor Pickering, "Patients with End Stage Renal Disease have very stiff arteries, and it has not been clear if oscillometric devices, which are used for home and ambulatory blood pressure monitoring, are accurate in such patients. Blood pressure measured at the time of dialysis may not accurately reflect the overall level of blood pressure in these patients, and home monitoring may prove to be very useful. Our research study demonstrated that the Microlife 3AC1-1PC digital home blood pressure monitor accurately measured blood pressure in patients with ESRD."

The patented algorithm used in the Microlife 3AC1-1PC is the same used in all of Microlife's upper arm monitors. This algorithm earned Microlife an A/A, the highest possible grade in accuracy, according to the British Hypertension Society's protocol as tested by unaffiliated researchers. Dr. Ken Kronhaus, M.D., renowned cardiologist and host of Good Day Health with Dr. Ken, says "Microlife's dedication to continued research and development of their blood pressure monitors make them my first choice when recommending a home monitor to my patients. I am confident that my patients are getting accurate results at home and this study proves it, even in very critical patients with End Stage Renal Disease, where measurement can be difficult."

Microlife is a global company and the world leader in the development and manufacturing of medical diagnostic equipment for home and institutional use. Blood pressure monitors, digital and infrared thermometers and peak flow meters are Microlife's core business. Microlife is a vertically integrated manufacturing company with a worldwide sales and distribution network. Microlife exports over 35 million medical devices each year from its ISO Certified (ISO9001 and ISO13485) factory in Shenzhen, China to all parts of the world. Each device utilizes leading edge technology for monitoring key health indicators. The Microlife family consists of more than 2,600 dedicated employees worldwide and is committed to continued research and development in medical devices that enable people to responsibly manage their own health. Visit Microlife USA's website at http://www.microlifeusa.com and http://www.manageyourhealth.org or call Microlife toll-free at 1-800-568-4147.

Product and company names herein may be the trademarks of their respective owners.


'/>"/>
SOURCE Microlife USA, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
2. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
3. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
4. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
5. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
6. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
7. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
8. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
9. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
10. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
11. Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... FRANCISCO , February 20, 2017 ... expected to reach USD 58.4 billion by 2025, ... Research, Inc. The market is driven by technological ... serve future growth opportunities to the market. For ... with an aim of identifying emerging viruses and ...
(Date:2/20/2017)... LONDON , February 20, 2017 Acute, Chronic ... is expected to grow at a CAGR of 7% from 2016-2021 and ... a CAGR of 6% from 2016 to 2027. The market is estimated ... ... Read on to discover how you can exploit the future business ...
(Date:2/18/2017)... 17, 2017   Parker Waichman LLP, ... rights of victims injured by medical devices, comments ... call for better reporting. Congress required hospitals to ... concerns involving power morcellators and duodenoscopes prompted the ... how hospitals report injuries and deaths related to ...
Breaking Medicine Technology:
(Date:2/20/2017)... ... 20, 2017 , ... Houston dentist , Dr. Nazari, ... at his office, Antoine Dental Center. Emergency dentistry encompasses many treatments for emergencies ... risk for serious complications and often experience severe pain. Not only does prompt ...
(Date:2/20/2017)... ... February 20, 2017 , ... Florida Hospital ... a new ultrasound-enhanced thrombolysis machine, a state-of-the-art device that breaks up life-threatening blood ... the Pepin Family Foundation. , “We greatly appreciate this gift from Constellation Brands. ...
(Date:2/19/2017)... RI (PRWEB) , ... February 19, 2017 , ... ... is proven to result in better care, and MEDfx and the Delaware Health ... state of Delaware. , As the nation’s first state-wide health information exchange, DHIN ...
(Date:2/18/2017)... ... 2017 , ... Butler Mobility invited Ken Matthews to visit its manufacturing facility ... Ken was impressed with the safety and reliability of the Stannah Stairlift as well ... This endorsement by Ken Matthews can be heard on News Radio WHP 580 ...
(Date:2/18/2017)... ... 2017 , ... A new directory from the Senior Veterans ... connect elderly veterans of America's armed forces to a range of senior care ... on this year's increase in the Veterans Pension with Aid & Attendance for ...
Breaking Medicine News(10 mins):